electroCore,

electroCore, EBIT Margin

The EBIT Margin (Operating Margin) of electroCore, (ECOR) as of Oct 18, 2026 is -42.68 %. In the previous year, EBIT Margin (Operating Margin) was -48.30 % — a change of -11.63% (higher).

EBIT Margin

-42.68 %

YoY

-11.63%

Last updated:

EBIT Margin (Operating Margin) of electroCore, is 2025 -42.68 % . EBIT Margin (Operating Margin) of electroCore, was 2024 -48.30 % . It decreases by -11.63% higher compared to the previous year.

For electroCore,, the operating (EBIT) margin of -42.7% is up versus -367.7% a few years ago.

The electroCore, EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2018
-5,494.07 USD
Jan 1, 2019
-1,928.17 USD
Jan 1, 2020
-707.94 USD
Jan 1, 2021
-367.69 USD
Jan 1, 2022
-266.22 USD
Jan 1, 2023
-117.31 USD
Jan 1, 2024
-48.30 USD
Jan 1, 2025
-42.68 USD
The electroCore, EBIT Margin history
YEAREBIT MarginYoY
-42.68 %-11.63%
-48.30 %-58.83%
-117.31 %-55.94%
-266.22 %-27.60%
-367.69 %-48.06%
-707.94 %-63.28%
-1,928.17 %-64.90%
-5,494.07 %+54.23%
-3,562.19 %-39.69%
-5,906.33 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

electroCore, Stock analysis

What does electroCore, do? electroCore, Inc. is a medical device company based in Basking Ridge, New Jersey, operating in the Health Care sector. The company focuses on non-invasive vagus nerve stimulation (nVNS) therapy, offering a hand-held device called gammaCore. This device provides non-drug treatment for adults experiencing episodic cluster and migraine pain. electroCore's technology targets primary headaches, including migraine and cluster headache, as well as related chronic conditions such as gastric motility disorders, psychiatric issues, sleep disorders, and pain disorders. The company went public via an IPO on June 22, 2018, and currently employs 83 full-time staff. Its headquarters are located in Basking Ridge, and it operates within the Health Care industry. electroCore's primary product, gammaCore, is designed for non-invasive cervical vagus nerve stimulation, aiming to address neurological, psychiatric, gastroenterological, and respiratory conditions. The company's website is https://www.electrocore.com/. electroCore is listed under the ticker ECOR with ISIN US28531P2020. The firm's commercial stage operations emphasize non-invasive therapeutic solutions without pharmaceutical intervention. electroCore, is one of the most popular companies on Eulerpool.

Frequently Asked Questions about electroCore, stock

EBIT Margin (Operating Margin) of electroCore, is -42.68 % in 2025.

EBIT Margin (Operating Margin) of electroCore, changed from -48.30 % to -42.68 %, representing a -11.63% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) electroCore, since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s electroCore, with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — electroCore,

All Key Metrics — electroCore,